LOS ANGELES CAPITAL MANAGEMENT LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$189,165
-32.4%
13,435
-25.8%
0.00%0.0%
Q1 2023$279,923
+37.9%
18,118
+65.2%
0.00%0.0%
Q3 2022$203,000
+41.0%
10,9700.0%0.00%0.0%
Q2 2022$144,000
+46.9%
10,970
+3.7%
0.00%
Q1 2022$98,000
-72.9%
10,580
+31.0%
0.00%
-100.0%
Q1 2021$362,000
-49.8%
8,075
-36.1%
0.00%
-33.3%
Q4 2020$721,000
+14.6%
12,641
+3.1%
0.00%0.0%
Q3 2020$629,000
+153.6%
12,261
+195.4%
0.00%
+200.0%
Q2 2020$248,0004,1510.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders